EUVIMEDEUVIMED entdecken
Crossref

Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA

Eric Sparkes iD, Axelle Timmerman, Jack W Markham, Rochelle Boyd, Rebecca Gordon, Katelyn A Walker, Richard C Kevin, David E Hibbs iD, Samuel D Banister iD, Elizabeth A Cairns, Christophe Stove iD, Adam Ametovski

ACS Chemical Neuroscience · 01.05.2024 · 15 (9) · 1787-1812

DOI: 10.1021/acschemneuro.3c00818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 10.04.2024. Verfasst von Eric Sparkes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney, New South Wales 2050, Australia. Hauptthemen laut MEDLINE: Cannabinoid Receptor Agonists, Receptor, Cannabinoid, CB1, Receptor, Cannabinoid, CB2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Health and Medical Research Council, Bijzonder Onderzoeksfonds UGent, Brain and Mind Centre, University of Sydney.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cannabinoid Receptor AgonistsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2HumansHEK293 CellsStructure-Activity RelationshipAnimals

Stichwörter der Autor:innen

ADB-HEXINACANPSSCRAcannabinoidpharmacology

Substanzen

Cannabinoid Receptor AgonistsReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2

Autor:innen und Institutionen

  • Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney, New South Wales 2050, Australia.
  • School of Chemistry, The University of Sydney, Sydney, New South Wales 2050, Australia.
  • Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium.
  • Sydney Pharmacy School, The University of Sydney, Sydney, New South Wales 2050, Australia.
  • School of Psychology, The University of Sydney, Sydney, New South Wales 2050, Australia.
  • Department of Clinical Pharmacology and Toxicology, St Vincent's Hospital Sydney, Sydney, New South Wales 2010, Australia.

ORCID-Profile: Eric Sparkes, David E Hibbs, Samuel D Banister, Christophe Stove

Förderung

  • National Health and Medical Research Council
  • Bijzonder Onderzoeksfonds UGent
  • Brain and Mind Centre, University of Sydney

Zitieren

APA

Sparkes, E., Timmerman, A., Markham, J. W., Boyd, R., Gordon, R., Walker, K. A., Kevin, R. C., Hibbs, D. E., Banister, S. D., Cairns, E. A., Stove, C., & Ametovski, A. (2024). Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA. ACS Chemical Neuroscience, 15(9), 1787-1812. https://doi.org/10.1021/acschemneuro.3c00818

Vancouver

Sparkes E, Timmerman A, Markham JW, Boyd R, Gordon R, Walker KA, et al. Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA. ACS Chemical Neuroscience. 2024;15(9):1787-1812. doi:10.1021/acschemneuro.3c00818

BibTeX
@article{Sparkes2024,
  author = {Sparkes, Eric and Timmerman, Axelle and Markham, Jack W and Boyd, Rochelle and Gordon, Rebecca and Walker, Katelyn A and Kevin, Richard C and Hibbs, David E and Banister, Samuel D and Cairns, Elizabeth A and Stove, Christophe and Ametovski, Adam},
  title = {Synthesis and Functional Evaluation of Synthetic Cannabinoid Receptor Agonists Related to ADB-HEXINACA},
  journal = {ACS Chemical Neuroscience},
  year = {2024},
  volume = {15},
  number = {9},
  pages = {1787--1812},
  doi = {10.1021/acschemneuro.3c00818}
}
Kostenlos starten →